Alerts will be sent to your verified email
Verify Email
SPARC
|
Sun Pharma Adv. Res
|
Navin Fluorine Intl
|
Glenmark Life Scienc
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceutical Sector
|
|||
|
R&D as a % of Total Sales
|
201.0 % | n/a | 3.3 % |
|
Financials
|
|||
|
5 yr Average ROE
|
204.42 % | 18.0 % | 77.76 % |
|
5yr average Equity Multiplier
|
-0.81 | 1.58 | 5.38 |
|
5yr Average Asset Turnover Ratio
|
0.52 | 0.52 | 0.75 |
|
5yr Avg Net Profit Margin
|
-157.48 % | 22.29 % | 20.48 % |
|
Price to Book
|
22.07 | 7.52 | 4.36 |
|
P/E
|
0.0 | 50.64 | 21.58 |
|
5yr Avg Cash Conversion Cycle
|
46.2 Days | 62.37 Days | 87.84 Days |
|
Inventory Days
|
0.0 | 51.77 Days | 90.19 Days |
|
Days Receivable
|
46.2 Days | 80.75 Days | 124.34 Days |
|
Days Payable
|
193.43 Days | 73.05 Days | 103.85 Days |
|
5yr Average Interest Coverage Ratio
|
-343.83 | 159.73 | 313.94 |
|
5yr Avg ROCE
|
549.64 % | 15.82 % | 95.75 % |
|
5yr Avg Operating Profit Margin
|
-146.72 % | 28.32 % | 30.33 % |
|
5 yr average Debt to Equity
|
-0.51 | 0.09 | 0.0 |
|
5yr CAGR Net Profit
|
8.88 % | 20.27 % | 19.01 % |
|
5yr Average Return on Assets
|
-63.27 % | 11.66 % | 15.3 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
65.67 % | 28.81 % | 82.85 % |
|
Share Pledged by Promoters
|
2.78 % | 3.15 % | 9.47 % |
|
Change in Promoter Holding (3 Yrs)
|
-2.79 % | -1.41 % | 0.01 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.24 % | 2.18 % | 0.63 % |
|
Sun Pharma Adv. Res
|
Navin Fluorine Intl
|
Glenmark Life Scienc
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
